The fragmented lung cancer screening pathway is failing one-third of patients—not because of lack of insurance or access. We've designed screening as a point-in-time test rather than a longitudinal program with built-in accountability. The solutions are within reach: replicate proven workflows from breast cancer screening, leverage AI to surface guideline-concordant next steps directly in the clinical workflow, and integrate advance care planning early so we align testing intensity with patient goals.
Read the analysis below…
